Matches in Nanopublications for { ?s ?p "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP780539.RAzCDlXSOO7i4QJZMmUP3H52P7L75Sf7gTW5_oQfuq0dM130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780539.RAzCDlXSOO7i4QJZMmUP3H52P7L75Sf7gTW5_oQfuq0dM130_provenance.
- NP596136.RABrK-4CTWFYAZvclBNioR5ni8800LAywxjMhS1Xzf8Mg130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596136.RABrK-4CTWFYAZvclBNioR5ni8800LAywxjMhS1Xzf8Mg130_provenance.
- NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596138.RAcfLHLkyq_WrfAXRVxKpbQBZf_J6re9MFihvngffNZjU130_provenance.
- assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP596137.RALtsgvAj9b1QsyDgPQyJwT0pR2G3aTSvbAYNYUB-DgDc130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596137.RALtsgvAj9b1QsyDgPQyJwT0pR2G3aTSvbAYNYUB-DgDc130_provenance.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.